Want to see BXLC full AI Analyst Report?
Top Page
Bexil
(OTC:BXLC)
Select Model
Select Model
Rating:74Outperform
Price Target:
$70.00
▲(12.00% Upside)
Action:Reiterated
Date:08/17/26
The score is led by strong financial positioning (notably a debt-free balance sheet and improved profitability) and a low P/E that supports valuation. These positives are tempered by weaker technical momentum (negative MACD, low RSI, and price below longer-term moving averages) and fundamental durability concerns from shrinking TTM revenue and weaker cash conversion versus net income.
Positive Factors
Debt-Free Balance Sheet
Minimal leverage limits interest burden and refinancing risk, giving Bexil greater resilience through weaker operating periods. The substantial equity base also provides financial flexibility to preserve operations or pursue opportunities without relying heavily on external funding.
Negative Factors
Shrinking Revenue Base
A substantial top-line contraction challenges the durability of the current earnings profile and may indicate reduced business activity or fewer recurring opportunities. Sustained revenue pressure could eventually limit operating scale, investment capacity, and future profit growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-Free Balance Sheet
Minimal leverage limits interest burden and refinancing risk, giving Bexil greater resilience through weaker operating periods. The substantial equity base also provides financial flexibility to preserve operations or pursue opportunities without relying heavily on external funding.
Read all positive factors
Bexil (BXLC) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$63.22M
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)4.8
Beta (1Y)0.23
Revenue Growth29.83%
EPS Growth100.03%
CountryUS
Employees5
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)12.63
Shares Outstanding1,011,592
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.24
Price to Sales (P/S)11.94
P/FCF Ratio13.97
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bexil Business Overview & Revenue Model
Company Description
Bexil Corporation, established in 1996 and headquartered in Millbrook, New York, primarily operates in the United States. The company focuses on investment management and securities trading, conducting these activities through its various subsidia...
How the Company Makes Money
null...
Bexil Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
89
Very Positive
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.67M | 3.13M | 5.12M | 5.91M | 2.75M | 2.84M |
| Gross Profit | 3.67M | 3.13M | 5.12M | 5.91M | 2.75M | 8.70M |
| EBITDA | 9.14M | 7.40M | 3.59M | 4.26M | -3.27M | 5.36M |
| Net Income | 6.92M | 5.63M | 3.12M | 3.15M | -1.76M | 6.49M |
Balance Sheet | ||||||
| Total Assets | 32.06M | 30.48M | 26.60M | 28.94M | 26.24M | 28.14M |
| Cash, Cash Equivalents and Short-Term Investments | 2.34M | 3.12M | 23.84M | 25.55M | 18.33M | 23.65M |
| Total Debt | 160.51K | 0.00 | 73.47K | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 788.54K | 447.76K | 305.21K | 1.20M | 155.81K | 261.00K |
| Stockholders Equity | 31.46M | 30.22M | 26.47M | 27.25M | 26.26M | 28.05M |
Cash Flow | ||||||
| Free Cash Flow | 2.68M | 2.68M | 443.12K | 1.73M | 2.29M | 2.56M |
| Operating Cash Flow | 2.68M | 2.68M | 443.12K | 1.73M | 2.29M | 2.56M |
| Investing Cash Flow | -146.69K | -9.79K | -1.29M | 1.37M | -3.56M | -354.68K |
| Financing Cash Flow | -2.01M | -2.31M | -3.89M | -1.38M | 92.30K | -2.23M |
Bexil Technical Analysis
Neutral
62.50
Price Trends
62.60
Negative
63.80
Negative
64.40
Negative
Market Momentum
-0.15
Negative
50.76
Neutral
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BXLC, the sentiment is Neutral. The current price of 62.5 is above the 20-day moving average (MA) of 62.38, below the 50-day MA of 62.60, and below the 200-day MA of 64.40, indicating a neutral trend. The MACD of -0.15 indicates Negative momentum. The RSI at 50.76 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BXLC.
Bexil Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $63.22M | 4.75 | 16.33% | ― | 29.83% | 100.03% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | $24.74M | 8.22 | 30.08% | ― | 8.29% | ― | |
53 Neutral | $33.35M | -269.75 | -0.28% | 16.23% | -71.45% | 97.98% | |
47 Neutral | $41.53M | -19.61 | -9.56% | ― | -7.04% | 66.60% |
* Financial Sector Average
BXLC
Bexil
62.50
-2.50
-3.85%
RAND
Rand Capital
10.79
-3.43
-24.14%
MGLD
Marygold Companies
1.00
0.08
8.81%
BCG
Binah Capital Group
1.45
-0.51
-26.02%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.